Asgard Therapeutics New York Sweden

Asgard Therapeutics strengthens its Board of Directors and Advisory Board with leading experts in drug development and cancer immunotherapy

Highly experienced biopharma executive Dr Cristina Csimma joins Asgard's Board of Directors, while esteemed immunologists Prof Ignacio Melero and Prof Brian Brown join Advisory BoardAppointments strengthen Asgard's team as it progresses IND-enabling studies for its lead asset AT-108 – a first-in-class, off-the-shelf cell reprogramming therapy that leads to personalized and potent anti-cancer immune responsesView original content:https://www.prnewswire.co.uk/news-releases/asgard-therapeutics-strengthens-its-board-of-directors-and-advisory-board-with-leading-experts-in-drug-development-and-cancer-immunotherapy-302471674.html